Drant Ryan D
CIK 0001302106 Name as filed on the most recent filing
Filed as Drant Ryan D (70)
111 transaction lines · from 70 filings · filed 2005-05-23 to 2015-06-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Ardelyx, Inc. 2 filings
- ISSUER Tracon Pharmaceuticals, Inc. 1 filings
- ISSUER Zosano Pharma Corp 1 filings
- ISSUER Interleukin Genetics Inc 1 filings
- ISSUER Trevena Inc 2 filings
- ISSUER Tableau Software Inc 20 filings
- ISSUER Dermira, Inc. 1 filings
- ISSUER Sunesis Pharmaceuticals Inc 3 filings
- ISSUER Cvent Inc 3 filings
- ISSUER Epizyme, Inc. 3 filings
- ISSUER Loxo Oncology, Inc. 1 filings
- ISSUER Roka BioScience, Inc. 1 filings
- ISSUER Hyperion Therapeutics Inc 2 filings
- ISSUER TriVascular Technologies, Inc. 1 filings
- ISSUER Glycomimetics Inc 1 filings
- ISSUER Channeladvisor Corp 1 filings
- ISSUER Audience Inc 3 filings
- ISSUER Groupon, Inc. 2 filings
- ISSUER Tesaro, Inc. 2 filings
- ISSUER Omthera Pharmaceuticals, Inc. 1 filings
- ISSUER Millennial Media Inc. 1 filings
- ISSUER Fusion-Io, Inc. 6 filings
- ISSUER Supernus Pharmaceuticals Inc 1 filings
- ISSUER Amicus Therapeutics Inc 2 filings
- ISSUER Innerworkings Inc 3 filings
- ISSUER Clovis Oncology, Inc. 1 filings
- ISSUER ARYx Therapeutics, Inc. 1 filings
- ISSUER Peplin Inc 1 filings
- ISSUER Foxhollow Technologies, Inc. 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
99 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2015-06-05 |
Ardelyx, Inc. ARDX |
P, Open-market purchase | 1,869,159 acquired | 10.70 | 20,000,001.30 | Form 4, filing 0001181431-15-008054 | |
| 2015-02-04 |
Tracon Pharmaceuticals, Inc. TCON |
P, Open-market purchase | 500,000 acquired | 10.00 | 5,000,000.00 | Form 4, filing 0001181431-15-002004 | |
| 2015-01-30 |
Zosano Pharma Corp ZSAN |
P, Open-market purchase | 23,457 acquired | 11.00 | 258,027.00 | Form 4, filing 0001181431-15-001720 | |
| 2014-12-23 |
Interleukin Genetics Inc ILIU |
P, Open-market purchase | 19,868,965 acquired | 0.10 | 1,992,857.19 | Form 4, filing 0001181431-14-039781 | |
| 2014-12-10 |
Trevena Inc TRVN |
P, Open-market purchase | 1,000,000 acquired | 4.00 | 4,000,000.00 | Form 4, filing 0001181431-14-038451 | |
| 2014-11-10 |
Tableau Software Inc DATA |
S, Open-market sale | 1,697 disposed | 83.42 | 141,557.80 | Form 4, filing 0001181431-14-036182 | |
| 2014-10-08 |
Dermira, Inc. DERM |
P, Open-market purchase | 69,112 acquired | 16.00 | 1,105,792.00 | Form 4, filing 0001181431-14-034005 | |
| 2014-09-02 |
Tableau Software Inc DATA |
S, Open-market sale | 10,000 disposed | 66.79 | 667,893.00 | Form 4, filing 0001181431-14-030713 | |
| 2014-08-29 |
Sunesis Pharmaceuticals Inc SNSS |
S, Open-market sale | 11,600 disposed | 7.51 | 87,069.60 | Form 4, filing 0001181431-14-030572 | |
| 2014-08-28 |
Sunesis Pharmaceuticals Inc SNSS |
S, Open-market sale | 146,800 disposed | 7.87 | 1,154,846.24 | Form 4, filing 0001181431-14-030572 | |
| 2014-08-27 |
Tableau Software Inc DATA |
S, Open-market sale | 5,000 disposed | 62.50 | 312,500.00 | Form 4, filing 0001181431-14-030294 | |
| 2014-08-27 |
Sunesis Pharmaceuticals Inc SNSS |
S, Open-market sale | 108,300 disposed | 8.17 | 884,811.00 | Form 4, filing 0001181431-14-030572 | |
| 2014-08-26 |
Tableau Software Inc DATA |
S, Open-market sale | 5,000 disposed | 61.39 | 306,947.50 | Form 4, filing 0001181431-14-030294 | |
| 2014-08-25 |
Tableau Software Inc DATA |
S, Open-market sale | 7,099 disposed | 60.40 | 428,772.50 | Form 4, filing 0001181431-14-030157 | |
| 2014-08-22 |
Tableau Software Inc DATA |
S, Open-market sale | 5,000 disposed | 60.35 | 301,764.00 | Form 4, filing 0001181431-14-029998 | |
| 2014-08-22 |
Tableau Software Inc DATA |
S, Open-market sale | 27,921 disposed | 61.02 | 1,703,739.42 | Form 4, filing 0001181431-14-030046 | |
| 2014-08-22 |
Tableau Software Inc DATA |
S, Open-market sale | 24,391 disposed | 60.46 | 1,474,679.86 | Form 4, filing 0001181431-14-030046 | |
| 2014-08-21 |
Tableau Software Inc DATA |
S, Open-market sale | 20,652 disposed | 59.19 | 1,222,391.88 | Form 4, filing 0001181431-14-029998 | |
| 2014-08-21 |
Tableau Software Inc DATA |
S, Open-market sale | 9,348 disposed | 59.79 | 558,916.92 | Form 4, filing 0001181431-14-029998 | |
| 2014-08-19 |
Tableau Software Inc DATA |
S, Open-market sale | 5,000 disposed | 61.79 | 308,938.50 | Form 4, filing 0001181431-14-029693 | |
| 2014-08-18 |
Tableau Software Inc DATA |
S, Open-market sale | 10,000 disposed | 59.94 | 599,399.00 | Form 4, filing 0001181431-14-029532 | |
| 2014-08-15 |
Epizyme, Inc. EPZM |
S, Open-market sale | 3,027 disposed | 36.45 | 110,334.15 | Form 4, filing 0001181431-14-029544 | |
| 2014-08-15 |
Epizyme, Inc. EPZM |
S, Open-market sale | 455 disposed | 36.72 | 16,708.10 | Form 4, filing 0001181431-14-029544 | |
| 2014-08-15 |
Epizyme, Inc. EPZM |
S, Open-market sale | 384 disposed | 36.94 | 14,184.96 | Form 4, filing 0001181431-14-029544 | |
| 2014-08-15 |
Epizyme, Inc. EPZM |
S, Open-market sale | 195 disposed | 36.70 | 7,155.52 | Form 4, filing 0001181431-14-029544 | |
| 2014-08-15 |
Cvent Inc CVT |
S, Open-market sale | 2,641 disposed | 26.19 | 69,174.13 | Form 4, filing 0001181431-14-029557 | |
| 2014-08-15 |
Cvent Inc CVT |
S, Open-market sale | 353 disposed | 26.10 | 9,211.78 | Form 4, filing 0001181431-14-029557 | |
| 2014-08-15 |
Cvent Inc CVT |
S, Open-market sale | 151 disposed | 26.09 | 3,939.59 | Form 4, filing 0001181431-14-029557 | |
| 2014-08-13 |
Tableau Software Inc DATA |
S, Open-market sale | 1,000 disposed | 61.00 | 61,000.00 | Form 4, filing 0001181431-14-029141 | |
| 2014-08-13 |
Tableau Software Inc DATA |
S, Open-market sale | 1,000 disposed | 59.77 | 59,769.00 | Form 4, filing 0001181431-14-029141 | |
| 2014-08-12 |
Sunesis Pharmaceuticals Inc SNSS |
S, Open-market sale | 35,540 disposed | 6.76 | 240,189.98 | Form 4, filing 0001181431-14-028999 | |
| 2014-08-08 |
Sunesis Pharmaceuticals Inc SNSS |
S, Open-market sale | 675,000 disposed | 6.62 | 4,468,567.50 | Form 4, filing 0001181431-14-028999 | |
| 2014-08-06 |
Loxo Oncology, Inc. LOXO |
P, Open-market purchase | 230,769 acquired | 13.00 | 2,999,997.00 | Form 4, filing 0001181431-14-028427 | |
| 2014-07-22 |
Roka BioScience, Inc. ROKA |
P, Open-market purchase | 383,333 acquired | 12.00 | 4,599,996.00 | Form 4, filing 0001181431-14-027158 | |
| 2014-06-24 |
Ardelyx, Inc. ARDX |
P, Open-market purchase | 510,442 acquired | 14.00 | 7,146,188.00 | Form 4, filing 0001181431-14-025055 | |
| 2014-06-06 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 1,134 disposed | 26.90 | 30,506.19 | Form 4, filing 0001181431-14-023344 | |
| 2014-05-27 |
Tableau Software Inc DATA |
S, Open-market sale | 2,000 disposed | 63.00 | 126,000.00 | Form 4, filing 0001181431-14-021401 | |
| 2014-05-19 |
Tableau Software Inc DATA |
S, Open-market sale | 2,000 disposed | 58.00 | 116,001.60 | Form 4, filing 0001181431-14-020345 | |
| 2014-04-22 |
TriVascular Technologies, Inc. TRIV |
P, Open-market purchase | 583,333 acquired | 12.00 | 6,999,996.00 | Form 4, filing 0001181431-14-016852 | |
| 2014-03-07 |
Tableau Software Inc DATA |
S, Open-market sale | 11,433 disposed | 91.05 | 1,041,006.66 | Form 4, filing 0001181431-14-012101 | |
| 2014-03-07 |
Tableau Software Inc DATA |
S, Open-market sale | 10,700 disposed | 90.62 | 969,620.09 | Form 4, filing 0001181431-14-012101 | |
| 2014-03-07 |
Tableau Software Inc DATA |
S, Open-market sale | 1,491 disposed | 93.07 | 138,764.69 | Form 4, filing 0001181431-14-012101 | |
| 2014-03-06 |
Tableau Software Inc DATA |
S, Open-market sale | 22,146 disposed | 95.42 | 2,113,080.52 | Form 4, filing 0001181431-14-011593 | |
| 2014-03-06 |
Tableau Software Inc DATA |
S, Open-market sale | 20,152 disposed | 94.32 | 1,900,672.15 | Form 4, filing 0001181431-14-011593 | |
| 2014-03-06 |
Tableau Software Inc DATA |
S, Open-market sale | 7,702 disposed | 96.13 | 740,367.84 | Form 4, filing 0001181431-14-011593 | |
| 2014-03-05 |
Tableau Software Inc DATA |
S, Open-market sale | 20,500 disposed | 94.28 | 1,932,766.65 | Form 4, filing 0001181431-14-012598 | |
| 2014-03-05 |
Tableau Software Inc DATA |
S, Open-market sale | 14,500 disposed | 95.34 | 1,382,474.95 | Form 4, filing 0001181431-14-012598 | |
| 2014-03-04 |
Tableau Software Inc DATA |
S, Open-market sale | 20,000 disposed | 95.14 | 1,902,702.00 | Form 4, filing 0001181431-14-010969 | |
| 2014-03-04 |
Tableau Software Inc DATA |
S, Open-market sale | 13,960 disposed | 97.40 | 1,359,709.58 | Form 4, filing 0001181431-14-010969 | |
| 2014-03-04 |
Tableau Software Inc DATA |
S, Open-market sale | 10,804 disposed | 97.31 | 1,051,372.89 | Form 4, filing 0001181431-14-010969 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 20
- Open-market sale 79
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. DRANT RYAN D, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001302106
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6